00660.HK
Wai Chun Bio-Technology Limited
HKSE · Basic Materials · Chemicals · HK
HKD 0.39
+1.32%Income statement
| Metric | TTM | 2025 | 2025 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 919.6M | 568.3M | 377.2M | 773.7M | 671.5M |
| Cost of Revenue | 831.2M | 517.7M | 341.2M | 723.2M | 611.3M |
| Gross Profit | 88.5M | 50.5M | 36.0M | 50.4M | 60.1M |
| Operating Expenses | |||||
| R&D Expense | 1.6M | 1.6M | — | — | — |
| SG&A Expense | 79.5M | 46.8M | 30.6M | 35.9M | 39.3M |
| General & Admin Expense | 40.4M | 8.7M | 20.8M | 21.1M | 26.2M |
| Selling & Marketing Expense | 32.9M | 8.6M | 14.1M | 14.8M | 15.1M |
| Other Expenses | (4.5M) | (4.5M) | — | 316.0K | — |
| Total Operating Expenses | 76.6M | 43.9M | 30.6M | 35.9M | 39.3M |
| Cost and Expenses | 907.8M | 561.6M | 371.8M | 759.1M | 650.7M |
| Operating Income (EBIT) | 11.8M | 6.7M | 5.4M | 14.9M | 20.8M |
| Non-Operating | |||||
| Interest Income | — | — | 5.0K | 38.0K | 23.3K |
| Interest Expense | 27.5M | 8.3M | 13.7M | 17.1M | 14.0M |
| Net Interest Income | (27.5M) | (8.3M) | (13.7M) | (17.1M) | (13.9M) |
| Other Non-Op Income/Expense | (26.9M) | (7.7M) | (14.3M) | (20.6M) | (18.3M) |
| Non-Operating Income (excl Interest) | (471.0K) | 505.0K | (1.1M) | — | — |
| EBT (Pre-Tax Income) | (15.1M) | (1.1M) | (8.9M) | (5.7M) | 2.5M |
| Income Tax Expense | 5.5M | 2.5M | 1.8M | 4.4M | 3.4M |
| Bottom Line | |||||
| Net Income | (27.3M) | (6.9M) | (14.6M) | (15.4M) | (14.4M) |
| Earnings from Cont. Ops | (16.4M) | (3.4M) | (10.7M) | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (27.3M) | (6.9M) | (14.6M) | (15.4M) | (14.4M) |
| Per Share | |||||
| Basic EPS | (HK$0.16) | (HK$0.04) | (HK$0.08) | (HK$0.09) | (HK$0.09) |
| Diluted EPS | (HK$0.16) | (HK$0.04) | (HK$0.08) | (HK$0.09) | (HK$0.09) |
| Revenue Per Share | HK$5.15 | HK$3.18 | HK$2.17 | HK$4.58 | HK$4.01 |
| Shares | |||||
| Basic Shares Outstanding | 178.5M | 178.5M | 173.5M | 168.9M | 167.6M |
| Diluted Shares Outstanding | 178.5M | 178.5M | 173.5M | 168.9M | 167.6M |
| Profitability Metrics | |||||
| EBITDA | 33.3M | 13.8M | 17.9M | 14.9M | 31.6M |
| D&A | 21.0M | 7.7M | 13.2M | 14.1M | 10.8M |
| EBIT | 12.3M | 6.2M | 4.7M | 11.4M | 20.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025